http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111214450-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111214450-B
titleOfInvention Empagliflozin tablet and its preparation process
abstract The invention provides an empagliflozin tablet and a preparation process thereof, comprising empagliflozin, a carrier material and other pharmaceutically acceptable excipients, characterized in that the carrier material is composed of poloxamer and mannitol together . The preparation process of the empagliflozin tablet disclosed by the invention is simple to operate, and has the characteristics of fast dissolution rate, good stability and the like.
priorityDate 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11949646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421421992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758

Total number of triples: 33.